{rfName}
Di

Indexed in

License and use

Citations

61

Altmetrics

Analysis of institutional authors

Bru Saumell, ConxitaAuthorForner AAuthorReig MAuthorBurrel MAuthorLlovet JAuthorAyuso CAuthorBruix JAuthor

Share

Publications
>
Clinical Guidelines

Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH

Publicated to:Medicina Clinica. 146 (11): 511.e1-511.e22 - 2016-06-03 146(11), DOI: 10.1016/j.medcli.2016.01.028

Authors: Forner A; Reig M; Varela M; Burrel M; Feliu J; Briceño J; Sastre J; Martí-Bonmati L; Llovet JM; Bilbao JI; Sangro B; Pardo F; Ayuso C; Bru C; Tabernero J; Bruix J

Affiliations

Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas - Author
Fetge, Sistema Digestiu i Metabolisme. Oncologia Hepática. Institut d'Investigacions Biomèdiques August Pi i Sunyer - Author
Hospital Clinico San Carlos de Madrid - Author
Hospital Clínico Universitario de Valencia - Author
Hospital Universitari Vall d'Hebron - Author
Hospital Universitario Central de Asturias - Author
Hospital Universitario La Paz - Author
Hospital Universitario Reina Sofía - Author
Icahn School of Medicine at Mount Sinai - Author
Universidad de Navarra - Author
Universitat de Barcelona - Author
See more

Abstract

Hepatocellular carcinoma is the most common primary malignancy of the liver and one of the most frequent causes of death in patients with liver cirrhosis. Simultaneously with the recognition of the clinical relevance of this neoplasm, in recent years there have been important developments in the diagnosis, staging and treatment of HCC. Consequently, the Asociación Española para el Estudio del Hígado has driven the need to update clinical practice guidelines, continuing to invite all the societies involved in the diagnosis and treatment of this disease to participate in the drafting and approval of the document (Sociedad Española de Trasplante Hepático, Sociedad Española de Radiología Médica, Sociedad Española de Radiología Vascular e Intervencionista y Sociedad Española de Oncología Médica). The clinical practice guidelines published in 2009 accepted as Clinical Practice Guidelines of the National Health System has been taken as reference document, incorporating the most important advances that have been made in recent years. The scientific evidence for the treatment of HCC has been evaluated according to the recommendations of the National Cancer Institute (www.cancer.gov) and the strength of recommendation is based on the GRADE system. Copyright © 2016 Elsevier España, S.L.U. All rights reserved.

Keywords

carcinoma hepatocelularcirrosis hepáticahepatocellular carcinomahígadoliverCarcinoma hepatocelularCarcinoma, hepatocellularCirrosis hepáticaCombined modality therapyEarly detection of cancerGlobal healthHepatocellular carcinomaHígadoHumansLiverLiver cirrhosisLiver neoplasmsPrognosisRisk assessment

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Medicina Clinica, and although the journal is classified in the quartile Q3 (Agencia WoS (JCR)), its regional focus and specialization in Medicine, General & Internal, give it significant recognition in a specific niche of scientific knowledge at an international level.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations from Scopus Elsevier, it yields a value for the Field-Weighted Citation Impact from the Scopus agency: 1.61, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Field Citation Ratio (FCR) from Dimensions: 11.67 (source consulted: Dimensions Jun 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-06-21, the following number of citations:

  • Scopus: 45
  • Europe PMC: 16
  • OpenCitations: 46

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-06-21:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 131.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 279 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 10.5.
  • The number of mentions on the social network Facebook: 1 (Altmetric).
  • The number of mentions on the social network X (formerly Twitter): 3 (Altmetric).
  • The number of mentions on Wikipedia: 2 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: United States of America.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Forner González, Alejandro) and Last Author (Bruix Tudo, Jordi).